EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: Exploring the benefits of digital health technologies in diabetes management

Anouk Geraets, Artur Rydosz, Frank Snoek

Frontiers in Clinical Diabetes and Healthcare · 16.06.2026 · 7

DOI: 10.3389/fcdhc.2026.1843985 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 16.06.2026. Verfasst von Anouk Geraets und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

promise and the complexity of digital diabetes management strategies. The collection highlights a shift in the field from technology-centered innovation towards implementation challenges involving patient engagement, workflow integration, equity, and responsible AI governance.A central contribution of this collection lies in its mapping of the evolving research landscape in digital diabetes management. The systematic review by Zhu et al. synthesizes 1,284 studies conducted across 101 countries between 2010 and 2024, identified AI as a rapidly expanding theme, particularly in predictive analytics and personalized care. This aligns with literature emphasizing the growing integration of machine learning into diabetes management for risk prediction and treatment optimization. In addition, a shift from technological innovation towards patient-centered approaches was observed. A trend echoed across several contributions in this Research Topic.From intervention studies, improvements in glycemic control emerged as a recurring finding, although with notable variability across intervention types and populations. Roth et al.demonstrated that the ESYSTA digital application significantly improved HbA1c and patientreported outcomes, such as well-being and diabetes-related distress, over six months. Similarly, Tang et al. reported improvements in HbA1c control rates, blood pressure, compliance rates, and user satisfaction among users of a mobile application. These findings are consistent with the systematic review by Stevens et al., which found greater HbA1c improvements in those who used DHTs.However, the collection also highlights conflicting findings that warrant critical reflection. monitoring systems in diabetic foot ulcer management. However, the rapid expansion of AI also raises important clinical, ethical, and regulatory concerns. Key challenges include data quality, algorithmic bias, limited transparency, insufficient prospective clinical validation, and poor interoperability with electronic health records and existing healthcare infrastructure. These limitations may hinder clinician and patient trust, adoption, and equitable implementation, particularly among underrepresented populations. As AI becomes increasingly integrated into diabetes care, robust governance frameworks that address cybersecurity, data privacy, regulatory oversight, and will be essential to ensure the safe, transparent, and equitable deployment of these technologies (5)(6)(7).Several priorities for future research emerge from this collection. First, there is a need to move beyond HbA1c as the sole primary outcome and incorporate more nuanced measures such as time-in-range, glycemic variability, and hypoglycemic events, along with patient-reported outcomes (8). Second, long-term studies are required to assess sustainability and real-world effectiveness (9). Third, implementation should be incorporated more systematically into digital health research to better understand and promote adoption, engagement, scalability, and health system integration (10,11). Finally, future studies should prioritize ethical AI development, equitable deployment strategies, and transparent governance structures (5)(6)(7).In conclusion, this Research Topic provides a timely, comprehensive and multifaceted overview of both the opportunities and limitations of DHTs in diabetes management. Digital technologies are rapidly evolving and can potentially improve monitoring, support self-management, and facilitate more personalized approaches to care. Yet, persistent challenges remain related to engagement sustainability, methodology, implementation, equity, and AI governance. Addressing these issues is needed to ensure that digital diabetes management evolves into a clinically effective, equitable, and sustainable component of future diabetes care.

Schlagwörter

Stichwörter der Autor:innen

continuous glucose monitoring (CGM)diabetes managementdigital healthmobile health (mHealth)technologies

Autor:innen und Institutionen

  • Department of Social Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Department of Electronics, AGH University of Krakow, Krakow, Poland.
  • Functional and Virtual 3D Medical Imaging Laboratory, Department of Diagnostic Imaging, University Hospital in Krakow, Krakow, Poland.
  • Department of Medical Psychology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Zitieren

APA

Geraets, A., Rydosz, A., & Snoek, F. (2026). Editorial: Exploring the benefits of digital health technologies in diabetes management. Frontiers in Clinical Diabetes and Healthcare, 7. https://doi.org/10.3389/fcdhc.2026.1843985

Vancouver

Geraets A, Rydosz A, Snoek F. Editorial: Exploring the benefits of digital health technologies in diabetes management. Frontiers in Clinical Diabetes and Healthcare. 2026;7. doi:10.3389/fcdhc.2026.1843985

BibTeX
@article{Geraets2026,
  author = {Geraets, Anouk and Rydosz, Artur and Snoek, Frank},
  title = {Editorial: Exploring the benefits of digital health technologies in diabetes management},
  journal = {Frontiers in Clinical Diabetes and Healthcare},
  year = {2026},
  volume = {7},
  doi = {10.3389/fcdhc.2026.1843985}
}
Kostenlos starten →